Intas Rumored As Another Suitor For Biogen’s Biosimilars Business

Reports Of Interest From Accord Parent Company Follow Earlier Samsung Bioepis Rumor

M&A written on red and blue blocks
Biogen has seen interest from multiple parties in its biosimilars business • Source: Shutterstock

More from Deals

More from Business